Today's Daily Dose brings you news about Axovant Gene's Parkinson's disease trial results, Corbus Pharma's cystic fibrosis trial data, Gamda's progress with Omidubicel, an investigational advanced cell therapy designed to enhance the life-saving benefits of bone marrow transplant, Merck KGa's out-licensing agreement with Novartis, and Santhera dumping DMD drug program Puldysa, among others.
from RTT - Biotech https://ift.tt/3nk7H45
via IFTTT
No comments:
Post a Comment